From AI X-Rays to Ultra-Short Drug Regimens: 2025’s Tuberculosis Breakthroughs
A sweeping 2025 review documents major advances in tuberculosis diagnostics, shorter all-oral drug regimens, novel compounds, vaccines, and disease reclassification, ...
A sweeping 2025 review documents major advances in tuberculosis diagnostics, shorter all-oral drug regimens, novel compounds, vaccines, and disease reclassification, ...
In a groundbreaking advancement destined to reshape our understanding of tuberculosis (TB), researchers at the Massachusetts Institute of Technology (MIT) ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine